Gossner G[au] - Search Results

Year	Number of Results
1999	1
2006	2
2007	1
2008	1
2009	2
2010	1
2011	1
2015	1
2016	1
2022	1
2024	0

1

Cho JE, Liu C, Gossner G, Nezhat FR. Cho JE, et al. Among authors: gossner g. Clin Obstet Gynecol. 2009 Sep;52(3):313-26. doi: 10.1097/GRF.0b013e3181b088d2. Clin Obstet Gynecol. 2009. PMID: 19661747 Review.

2

Clinical outcome of multidisciplinary treatment of vulvar necrotising fasciitis.

Rabbani AY, Kim S, Gossner G, Burke W, Sandoval S, Krajewski A, Pearl ML. Rabbani AY, et al. Among authors: gossner g. J Wound Care. 2022 Jul 1;31(Sup7):S20-S29. doi: 10.12968/jowc.2022.31.Sup7.S20. J Wound Care. 2022. PMID: 35797247 Review.

3

Robotic surgery in the obese gynecologic patient.

Burke WM, Gossner G, Goldman NA. Burke WM, et al. Among authors: gossner g. Clin Obstet Gynecol. 2011 Sep;54(3):420-30. doi: 10.1097/GRF.0b013e31822b37b1. Clin Obstet Gynecol. 2011. PMID: 21857172 Review.

4

Laparoscopic technology for the treatment of endometrial cancer.

Kueck AS, Gossner G, Burke WM, Reynolds RK. Kueck AS, et al. Among authors: gossner g. Int J Gynaecol Obstet. 2006 May;93(2):176-81. doi: 10.1016/j.ijgo.2006.02.013. Epub 2006 Mar 6. Int J Gynaecol Obstet. 2006. PMID: 16563396 Free article. Review. No abstract available.

5

Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.

Tan L, Wang W, He G, Kuick RD, Gossner G, Kueck AS, Wahl H, Opipari AW, Liu JR. Tan L, et al. Among authors: gossner g. Cancer. 2016 Mar 1;122(5):722-9. doi: 10.1002/cncr.29793. Epub 2015 Nov 30. Cancer. 2016. PMID: 26619367 Free article.

6

Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.

Loar P, Wahl H, Kshirsagar M, Gossner G, Griffith K, Liu JR. Loar P, et al. Among authors: gossner g. Am J Obstet Gynecol. 2010 Apr;202(4):371.e1-8. doi: 10.1016/j.ajog.2009.10.883. Am J Obstet Gynecol. 2010. PMID: 20138251

7

Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.

Gossner G, Choi M, Tan L, Fogoros S, Griffith KA, Kuenker M, Liu JR. Gossner G, et al. Gynecol Oncol. 2007 Apr;105(1):23-30. doi: 10.1016/j.ygyno.2006.11.009. Epub 2007 Jan 17. Gynecol Oncol. 2007. PMID: 17234261

8

Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.

Kim H, Wu R, Cho KR, Thomas DG, Gossner G, Liu JR, Giordano TJ, Shedden KA, Misek DE, Lubman DM. Kim H, et al. Among authors: gossner g. Proteomics Clin Appl. 2008 Mar 7;2(4):571-584. doi: 10.1002/prca.200780004. Proteomics Clin Appl. 2008. PMID: 20523764 Free PMC article.

9

CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan.

Gossner G, Coleman RL, Mutch DG, Horowitz NS, Rader JS, Gibb RK, Powell MA, Herzog TJ. Gossner G, et al. Gynecol Oncol. 2006 Oct;103(1):212-8. doi: 10.1016/j.ygyno.2006.02.026. Epub 2006 May 3. Gynecol Oncol. 2006. PMID: 16677696

10

Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage.

Wang Y, Wu R, Cho KR, Thomas DG, Gossner G, Liu JR, Giordano TJ, Shedden KA, Misek DE, Lubman DM. Wang Y, et al. Among authors: gossner g. J Proteome Res. 2009 Mar;8(3):1452-63. doi: 10.1021/pr800820z. J Proteome Res. 2009. PMID: 19159301 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year